{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:58:37Z","timestamp":1791003517037,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"crossref","award":["2021\/13429\u20131"],"award-info":[{"award-number":["2021\/13429\u20131"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>COVID-19 has created a significant global health emergency and triggered numerous seroepidemiological field tracing initiatives. The use of these samples becomes a timely tool for intensifying active case finding and early diagnosis of leprosy. This study aimed to conduct a seroepidemiological evaluation using leprosy biomarker antibodies against the Mce1A and PGL-I antigens, and to analyze the spatial distribution of both actively detected cases and antibody levels, thereby characterizing the geoepidemiological pattern of bacillary circulation, combined with case-screening strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A cross-sectional and geoepidemiological study was carried out using the biorepository of samples from the COVID-19 serosurvey in a municipality in southeastern Brazil. Screening diagnosis using LSQ and the artificial intelligence system MaLeSQs\n                      <jats:sup>\u00ae<\/jats:sup>\n                      was applied to investigate neurodermatological signs and symptoms of leprosy (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009224). IgA, IgM, and IgG anti-Mce1A and IgM anti-PGL-I antibodies were measured using indirect ELISA (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009195). Georeferencing was employed to create the distribution maps of individuals within the municipality. Global spatial autocorrelation analysis was performed and applied to the serological scores.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The responses to the clinical questionnaire reported the predominance of neurological signs and symptoms. Twelve new cases were diagnosed (32.4%), and the detection rate in the population sample evaluated was 6.15%. The IgA anti-Mce1A ELISA showed the highest seropositivity (55.3%), the highest rates [median\u2009=\u20090.93 (IQR\u2009=\u20090.59\u20131.41)]. The IgM and IgG anti-Mce1A serology showed higher rates (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001) as compared to the anti-PGL-I serology. The overlap of positivity with the antibodies tested highlights the greater involvement of double or triple positives when Mce1A serology was used. IgM anti-Mce1A serology was positive in 66.7% [8\/12 cases; median\u2009=\u20091.25 (IQR\u2009=\u20090.70\u20131.68)] of new cases detected. IgM anti-Mce1A showed the best serological performance, and its combination with MaLeSQs\n                      <jats:sup>\u00ae<\/jats:sup>\n                      (OR condition) achieved 100% sensitivity and NPV, with 68% specificity. Serology with the IgA antibody presented the highest rates in georeferencing analysis and served as an alert for contact with the bacillus. The sociodemographic variables tested did not exhibit statistical difference in spatial autocorrelation (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05), indicating the absence of a spatially clustered pattern for serological values in the analyzed territory.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      These findings identify IgM anti-Mce1A and MaLeSQs\n                      <jats:sup>\u00ae<\/jats:sup>\n                      as key tools to strengthen leprosy case-finding and screening efficiency. The study also revealed a diffuse pattern of transmission and exposure within the municipality and highlights the value of integrating serological biomarkers and digital diagnostic platforms to support earlier detection of leprosy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-12483-0","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T15:47:53Z","timestamp":1767800873000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Serum geoepidemiology of leprosy biomarkers in a city-wide COVID-19 survey in Brazil"],"prefix":"10.1186","volume":"26","author":[{"given":"Filipe Rocha","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateus Mendon\u00e7a Ramos","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Vitiritti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia Maria Lincoln","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia Aparecida","family":"de Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanderson Mayron Granemann","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josaf\u00e1 Gon\u00e7alves","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Bellissimo-Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo de Carvalho","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Andrey Cipriani","family":"Frade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"issue":"6","key":"12483_CR1","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1309\/AJCPP72FJZZRRVMM","volume":"130","author":"XY HAN","year":"2008","unstructured":"Han XY, et al. A new Mycobacterium species causing diffuse lepromatous leprosy. Am J Clin Pathol V. 2008;130(6):856\u201364.","journal-title":"Am J Clin Pathol V"},{"key":"12483_CR2","doi-asserted-by":"crossref","unstructured":"Britton W. J.; Lockwood D. N. Leprosy. Lancet 2004:363(9416);1209\u201319.","DOI":"10.1016\/S0140-6736(04)15952-7"},{"key":"12483_CR3","unstructured":"World health organization. Towards zero leprosy. Global leprosy (hansen\u2019s disease) strategy 2021\u20132030. 2021. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789290228509."},{"key":"12483_CR4","unstructured":"Pan american health organization \u2013 world health organization. leprosy (Hansen disease). Available from: https:\/\/www.paho.org\/en\/topics\/leprosy-hansen-disease. Access: feb 2025."},{"issue":"36","key":"12483_CR5","first-page":"421","volume":"96","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. Global leprosy (Hansen disease) update, 2020: impact of COVID-19 on global leprosy control. Wkly Epidemiol Rec. 2021;96(36):421\u201344.","journal-title":"Wkly Epidemiol Rec"},{"key":"12483_CR6","unstructured":"Brazil. Secretaria de Vigil\u00e2ncia em Sa\u00fade e Ambiente. Minist\u00e9rio da Sa\u00fade. Boletim epidemiol\u00f3gico 2024. 2024. Available from: https:\/\/www.gov.br\/saude\/pt-br\/centrais-de-conteudo\/publicacoes\/boletins\/epidemiologicos\/especiais\/2024\/be_hansen-2024_19jan_final.pdf."},{"key":"12483_CR7","doi-asserted-by":"crossref","unstructured":"da Paz da WS et al. Impact of the COVID-19 pandemic on the diagnosis of leprosy in Brazil: an ecological and population-based study. The Lancet Regional Health \u2013 Americas 9;100181.","DOI":"10.1016\/j.lana.2021.100181"},{"issue":"1","key":"12483_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/imr.12966","volume":"301","author":"A van HOOIJ","year":"2021","unstructured":"van Hooij A, Geluk A. In search of biomarkers for leprosy by unraveling the host immune response to Mycobacterium leprae. Immunol Rev. 2021;301(1):175\u201392.","journal-title":"Immunol Rev"},{"key":"12483_CR9","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1128\/JCM.41.5.1991-1995.2003","volume":"41","author":"S BUHRER-SEKULA","year":"2003","unstructured":"Buhrer-Sekula S, et al. Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J Clin Microbiol 2003;41:1991\u20135.","journal-title":"J Clin Microbiol V"},{"key":"12483_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1128\/CVI.00372-07","volume":"15","author":"IM GOULART","year":"2008","unstructured":"Goulart IM, et al. Risk and protective factors for leprosy development determined by epidemiological surveillance of household contacts. Clin Vaccine Immunol V. 2008;15:101\u20135.","journal-title":"Clin Vaccine Immunol V"},{"issue":"1","key":"12483_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1590\/S0074-02762012000900014","volume":"107","author":"JS SPENCER","year":"2012","unstructured":"Spencer JS, et al. Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosy. Mem Inst Oswaldo Cruz 2012;107(1):79\u201389.","journal-title":"Mem Inst Oswaldo Cruz V"},{"issue":"1","key":"12483_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1590\/S0074-02762012000900011","volume":"107","author":"JG BARRETO","year":"2012","unstructured":"Barreto JG, et al. High rates of undiagnosed leprosy and subclinical infection amongst school children in the Amazon region. Mem Inst Oswaldo Cruz 2012;107(1):60\u20137.","journal-title":"Mem Inst Oswaldo Cruz V"},{"key":"12483_CR13","first-page":"897","volume":"11","author":"JT DOUGLAS","year":"2004","unstructured":"Douglas JT, et al. Prospective study of serological conversion as a risk factor for development of leprosy among household contacts. Clin Diagn Lab Immunol V. 2004;11:897\u2013900.","journal-title":"Clin Diagn Lab Immunol V"},{"key":"12483_CR14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1128\/CVI.00472-10","volume":"18","author":"JS SPENCER","year":"2011","unstructured":"Spencer JS, et al. Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and Recombinant proteins to define disease subtype-specific antigenic profiles in leprosy. Clin Vaccine Immunol. 2011;18:260\u20137.","journal-title":"Clin Vaccine Immunol"},{"key":"12483_CR15","doi-asserted-by":"crossref","unstructured":"Arruda S. et al. Cloning of an M. tuberculosis DNA fragment associated with entry and survival inside cells. Sci 1993;261(5127):1454\u20137.","DOI":"10.1126\/science.8367727"},{"key":"12483_CR16","doi-asserted-by":"crossref","unstructured":"Sato N et al. Recombinant Mycobacterium leprae protein associated with entry into mammalian cells of respiratory and skin components. J Dermatol Sci, 2007;46;101\u2009\u2013\u200910.","DOI":"10.1016\/j.jdermsci.2007.01.006"},{"key":"12483_CR17","doi-asserted-by":"crossref","unstructured":"Fadlitha VB et al. The unique tropism of Mycobacterium leprae to the nasal epithelial cells can be explained by the mammalian cell entry protein 1A. PLoS Negl Trop Dis. 2019;13(3):e0006704.","DOI":"10.1371\/journal.pntd.0006704"},{"issue":"1","key":"12483_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1590\/0037-8682-0230-2016","volume":"50","author":"A QUEIROZ","year":"2017","unstructured":"Queiroz A, Riley L. Bacterial immunostat: Mycobacterium tuberculosis lipids and their role in the host immune response. Rev Soc Bras Med Trop. 2017;50(1):9\u201318.","journal-title":"Rev Soc Bras Med Trop V"},{"issue":"5","key":"12483_CR19","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1107\/S2052252521006199","volume":"8","author":"P Asthana","year":"2021","unstructured":"ASTHANA P, et al. Structural insights into the substrate-binding proteins Mce1A and Mce4A from Mycobacterium tuberculosis. IUCrJ V. 2021;8(5):757\u201374.","journal-title":"IUCrJ V"},{"key":"12483_CR20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1590\/0074-02760160549","volume":"112","author":"FR Lima","year":"2017","unstructured":"Lima FR, et al. ELISA-based assay of Immunoglobulin G antibodies against mammalian cell entry 1A (Mce1A) protein: a novel diagnostic approach for leprosy. Mem Inst Oswaldo Cruz. 2017;112:844\u20139. https:\/\/doi.org\/10.1590\/0074-02760160549.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"12483_CR21","doi-asserted-by":"publisher","first-page":"855787","DOI":"10.3389\/fmed.2022.855787","volume":"9","author":"FR Lima","year":"2022","unstructured":"Lima FR, et al. Serological immunoassay for hansen\u2019s disease diagnosis and monitoring treatment: Anti-Mce1A antibody response among hansen\u2019s disease patients and their household contacts in Northeastern Brazil. Front Med. 2022;9:855787. https:\/\/doi.org\/10.3389\/fmed.2022.855787.","journal-title":"Front Med"},{"key":"12483_CR22","doi-asserted-by":"publisher","first-page":"1048759","DOI":"10.3389\/fmed.2023.1048759","volume":"10","author":"FR Lima","year":"2023","unstructured":"Lima FR, et al. Serological testing for hansen\u2019s disease diagnosis: clinical significance and performance of IgA, IgM, and IgG antibodies against Mce1A protein. Front Med (Lausanne). 2023;10:1048759. https:\/\/doi.org\/10.3389\/fmed.2023.1048759.","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"12483_CR23","doi-asserted-by":"publisher","first-page":"101634","DOI":"10.1016\/j.bjid.2021.101634","volume":"25","author":"F Bernardes-Filho","year":"2021","unstructured":"Bernardes-Filho F. Leprosy case series in the emergency room: a warning sign for a challenging diagnosis. Braz J Infect Dis. 2021;25(5):101634. https:\/\/doi.org\/10.1016\/j.bjid.2021.101634.","journal-title":"Braz J Infect Dis"},{"key":"12483_CR24","doi-asserted-by":"publisher","first-page":"e02102021","DOI":"10.1590\/0037-8682-0210-2021","volume":"54","author":"EZ Martinez","year":"2021","unstructured":"Martinez EZ, Passos ADC, Fabbro ALD, Silva ASD, Escarso AC, et al. Prevalence of virological and serological markers of SARS-CoV-2 infection in the population of Ribeir\u00e3o Preto, Southeast brazil: an epidemiological survey. Rev Soc Bras Med Trop. 2021;54:e02102021. https:\/\/doi.org\/10.1590\/0037-8682-0210-2021.","journal-title":"Rev Soc Bras Med Trop"},{"key":"12483_CR25","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1017\/S095026882300119X","volume":"151","author":"FS de Carvalho","year":"2023","unstructured":"de Carvalho FS, Slack SD, Barbosa-J\u00fanior F, de Campos MR, Castro GS, et al. Genomic epidemiology of SARS-CoV-2 in large university hospital cohort: the UnCoVER-Brazil project. Epidemiol Infect. 2023;151:e126. https:\/\/doi.org\/10.1017\/S095026882300119X.","journal-title":"Epidemiol Infect"},{"key":"12483_CR26","unstructured":"IBGE 2020. Panorama de Ribeir\u00e3o Preto. Dispon\u00edvel em: https:\/\/cidades.ibge.gov.br\/brasil\/sp\/ribeirao-preto\/panorama"},{"issue":"7","key":"12483_CR27","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1590\/1413-81232015207.10742014","volume":"20","author":"SCHUMANN LRMA; MOURA LBA","year":"2015","unstructured":"Schumann LRMA; Moura LBA. \u00cdndices sint\u00e9ticos de vulnerabilidade: Uma revis\u00e3o integrativa de literatura. Cien Saude Colet. 2015;20(7):2105\u201320.","journal-title":"Cien Saude Colet"},{"key":"12483_CR28","doi-asserted-by":"publisher","first-page":"6912","DOI":"10.1038\/s41598-025-91462-6","volume":"15","author":"MMR Sim\u00d5es","year":"2025","unstructured":"Sim\u00f5es MMR, et al. Development and validation of a machine learning approach for screening new leprosy cases based on the leprosy suspicion questionnaire. Sci Rep. 2025;15:6912.","journal-title":"Sci Rep"},{"issue":"12","key":"12483_CR29","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1590\/0074-02760170173","volume":"112","author":"F Bernardes","year":"2017","unstructured":"Bernardes F, Filho, Paula NA, Leite MN, Abi-Rached TLC, Vernal S, Silva MBD, Barreto JG, Spencer JS, Frade MAC. Evidence of hidden leprosy in a supposedly low endemic area of Brazil. Mem Inst Oswaldo Cruz. 2017;112(12):822\u20138. https:\/\/doi.org\/10.1590\/0074-02760170173.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"12483_CR30","doi-asserted-by":"publisher","first-page":"972244","DOI":"10.3389\/fmed.2022.972244","volume":"9","author":"FR Lima","year":"2022","unstructured":"Lima FR, de Paula NA, Sim\u00f5es MMR, Manso GMC, Albertino GS, Felisbino GC, et al. Bacilloscopy and polymerase chain reaction of slit-skin smears and anti-phenolic glycolipid-I serology for hansen\u2019s disease diagnosis. Front Med. 2022;9:972244. https:\/\/doi.org\/10.3389\/fmed.2022.972244.","journal-title":"Front Med"},{"key":"12483_CR31","volume-title":"Guidelines for the diagnosis, treatment and prevention of leprosy","author":"WHO","year":"2018","unstructured":"WHO. Guidelines for the diagnosis, treatment and prevention of leprosy. New Delhi: World Health Organization; 2018."},{"key":"12483_CR32","first-page":"60","volume-title":"Diretrizes Para vigil\u00e2ncia, aten\u00e7\u00e3o e elimina\u00e7\u00e3o Da Hansen\u00edase Como problema de sa\u00fade p\u00fablica: manual t\u00e9cnico-operacional","author":"BRAZIL","year":"2016","unstructured":"BRAZIL. Minist\u00e9rio Da Sa\u00fade. Secretaria de Vigil\u00e2ncia Em Sa\u00fade. Departamento de Vigil\u00e2ncia Das Doen\u00e7as. Diretrizes Para vigil\u00e2ncia, aten\u00e7\u00e3o e elimina\u00e7\u00e3o Da Hansen\u00edase Como problema de sa\u00fade p\u00fablica: manual t\u00e9cnico-operacional. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade; 2016. p. 60."},{"key":"12483_CR33","doi-asserted-by":"publisher","first-page":"807","DOI":"10.25259\/IJDVL_622_19","volume":"87","author":"MAC FRADE","year":"2021","unstructured":"FRADE MAC, et al. Semmes-Weinstein monofilament: A tool to quantify skin sensation in macular lesions for leprosy diagnosis. Indian J Dermatol Venereol Leprol. 2021;87:807\u201315.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"12483_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-35973-1_817","volume-title":"Encyclopedia of GIS","author":"X Zhou","year":"2008","unstructured":"Zhou X, Lin H. Moran\u2019s I. In: Shekhar S, Xiong H, editors. Encyclopedia of GIS. Boston, MA: Springer; 2008. https:\/\/doi.org\/10.1007\/978-0-387-35973-1_817."},{"key":"12483_CR35","doi-asserted-by":"publisher","unstructured":"Barbosa AM, Silva SUD, Toledo ACCG, Abreu MAMM. Seroepidemiologic survey of the household contacts of leprosy patients. Rev Assoc Med Bras. 2022;68(10):1389\u20131393. https:\/\/doi.org\/10.1590\/1806-9282.20220248. PMID: 36417641; PMCID: PMC9683918.","DOI":"10.1590\/1806-9282.20220248"},{"issue":"8","key":"12483_CR36","doi-asserted-by":"publisher","first-page":"e0008563","DOI":"10.1371\/journal.pntd.0008563","volume":"14","author":"N Wang","year":"2020","unstructured":"Wang N, Chu T, Li F, Wang Z, Liu D, Chen M, Wang H, Niu G, Liu D, Zhang M, Xu Y, Zhang Y, Li J, Li Z, You J, Mao L, Li H, Chen Y, Liu H, Zhang F. The role of an active surveillance strategy of targeting household and neighborhood contacts related to leprosy cases released from treatment in a low-endemic area of China. PLoS Negl Trop Dis. 2020;14(8):e0008563. https:\/\/doi.org\/10.1371\/journal.pntd.0008563.","journal-title":"PLoS Negl Trop Dis"},{"key":"12483_CR37","doi-asserted-by":"publisher","first-page":"1243571","DOI":"10.3389\/fmed.2023.1243571","volume":"10","author":"RC Bouth","year":"2023","unstructured":"Bouth RC, Gobbo AR, Barreto JG, do Carmo Pinto PD, Bittencourt MS, Frade MAC, Nascimento AC, Bandeira SS, da Costa PF, Conde GAB, Avanzi C, Ribeiro-Dos-Santos \u00c2, Spencer JS, da Silva MB, Salgado CG. Specialized active leprosy search strategies in an endemic area of the Brazilian Amazon identifies a hypermutated Mycobacterium leprae strain causing primary drug resistance. Front Med (Lausanne). 2023;10:1243571. https:\/\/doi.org\/10.3389\/fmed.2023.1243571.","journal-title":"Front Med (Lausanne)"},{"key":"12483_CR38","doi-asserted-by":"publisher","first-page":"16675","DOI":"10.1038\/s41598-019-52640-5","volume":"9","author":"FSN Manta","year":"2019","unstructured":"Manta FSN, Barbieri RR, Moreira SJM, et al. Quantitative PCR for leprosy diagnosis and monitoring in household contacts: A follow-up study, 2011\u20132018. Sci Rep. 2019;9:16675. https:\/\/doi.org\/10.1038\/s41598-019-52640-5.","journal-title":"Sci Rep"},{"issue":"6","key":"12483_CR39","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1001\/jamadermatol.2020.0653","volume":"156","author":"CSS Teixeira","year":"2020","unstructured":"Teixeira CSS, Pescarini JM, Alves FJO, Nery JS, Sanchez MN, Teles C, Ichihara MYT, Ramond A, Smeeth L, Fernandes Penna ML, Rodrigues LC, Brickley EB, Penna GO, Barreto ML, Silva RCR. Incidence of and factors associated with leprosy among household contacts of patients with leprosy in Brazil. JAMA Dermatol. 2020;156(6):640\u20138. https:\/\/doi.org\/10.1001\/jamadermatol.2020.0653.","journal-title":"JAMA Dermatol"},{"key":"12483_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ebiom.2019.09.028","volume":"48","author":"N Nausch","year":"2019","unstructured":"Nausch N, Jacobsen M. Identification and validation of host biomarkers for leprosy: A step forward to Establish point-of-care tests. EBioMedicine. 2019;48:9\u201310. https:\/\/doi.org\/10.1016\/j.ebiom.2019.09.028. Epub 2019 Oct 17.","journal-title":"EBioMedicine"},{"issue":"3","key":"12483_CR41","doi-asserted-by":"publisher","first-page":"e0003895","DOI":"10.1371\/journal.pntd.0003895","volume":"10","author":"PJ Hotez","year":"2016","unstructured":"Hotez PJ, Pecoul B, Rijal S, Boehme C, Aksoy S, Malecela M, Tapia-Conyer R, Reeder JC. Eliminating the neglected tropical diseases: translational science and new technologies. PLoS Negl Trop Dis. 2016;10(3):e0003895. https:\/\/doi.org\/10.1371\/journal.pntd.0003895.","journal-title":"PLoS Negl Trop Dis"},{"key":"12483_CR42","doi-asserted-by":"publisher","first-page":"e220317","DOI":"10.1590\/0074-02760220317","volume":"117","author":"CP Romero","year":"2022","unstructured":"Romero CP, Castro R, do Brasil PEA, Pereira DR, Pinheiro RO, Toscano CM, de Oliveira MRF. Accuracy of rapid point-of-care serological tests for leprosy diagnosis: a systematic review and meta-analysis. Mem Inst Oswaldo Cruz. 2022;117:e220317. https:\/\/doi.org\/10.1590\/0074-02760220317.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"22","key":"12483_CR43","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1177\/15353702231209422","volume":"248","author":"L Lopes-Luz","year":"2023","unstructured":"Lopes-Luz L, Saavedra DP, Foga\u00e7a MBT, B\u00fchrer-S\u00e9kula S, Stefani MMA. Challenges and advances in serological and molecular tests to aid leprosy diagnosis. Exp Biol Med (Maywood). 2023;248(22):2083\u201394. https:\/\/doi.org\/10.1177\/15353702231209422.","journal-title":"Exp Biol Med (Maywood)"},{"key":"12483_CR44","doi-asserted-by":"publisher","unstructured":"Ramos ACV, Martoreli J\u00fanior JF, Berra TZ, Alves YM, Barbosa TP, Scholze AR et al. Evolu\u00e7\u00e3o temporal e distribui\u00e7\u00e3o espacial da hansen\u00edase em munic\u00edpio de baixa endemicidade no estado de S\u00e3o Paulo. Epidemiol Serv Sa\u00fade [Internet]. 2022;31(1):e2021951. Available from: https:\/\/doi.org\/10.1590\/S1679-49742022000100018.","DOI":"10.1590\/S1679-49742022000100018"},{"key":"12483_CR45","doi-asserted-by":"publisher","DOI":"10.4081\/gh.2023.1227","author":"AG Carvalho","year":"2023","unstructured":"Carvalho AG, Dias CLH, Blok DJ, Ignotti E, Luz JGG. Intra-urban differences underlying leprosy Spatial distribution in central brazil: Geospatial techniques as potential tools for surveillance. Geospat Health. 2023. https:\/\/doi.org\/10.4081\/gh.2023.1227.","journal-title":"Geospat Health"},{"key":"12483_CR46","doi-asserted-by":"publisher","unstructured":"Martoreli J\u00fanior JF, Ramos ACV, Berra TZ, Nascimento MC, do, Tavares RBV, Moura HSD, de Mello DF, Alves JD, Arc\u00eancio RA. (2023). Clusters of risk for the occurrence of leprosy and disabilities in children under 15 years of age in Cuiab\u00e1: a Geospatial study. 26. https:\/\/doi.org\/10.1590\/1980-549720230006.2.","DOI":"10.1590\/1980-549720230006.2"},{"key":"12483_CR47","doi-asserted-by":"publisher","unstructured":"Vitiritti B, Lima FR, de Castilho NT, Somensi LB, Ogoshi RCS. Hidden leprosy in a low-endemic area in Southern Brazil: changes in endemicity following an active search. Braz J Infect Dis. 2024 Jul-Aug;28(4):103853. https:\/\/doi.org\/10.1016\/j.bjid.2024.103853. Epub 2024 Jul 22.","DOI":"10.1016\/j.bjid.2024.103853"},{"issue":"12","key":"12483_CR48","doi-asserted-by":"publisher","first-page":"e0008917","DOI":"10.1371\/journal.pntd.0008917","volume":"14","author":"F Bernardes Filho","year":"2020","unstructured":"Bernardes Filho F, Santana JM, de Almeida RCP, Voltan G, de Paula NA, Leite MN, Silva CML, Tormena C, Basoli L, Menezes J, da Silva MB, Spencer JS, Marques W Jr, Foss NT, Frade MAC. Leprosy in a prison population: A new active search strategy and a prospective clinical analysis. PLoS Negl Trop Dis. 2020;14(12):e0008917. https:\/\/doi.org\/10.1371\/journal.pntd.0008917.","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"12483_CR49","doi-asserted-by":"publisher","first-page":"e0009495","DOI":"10.1371\/journal.pntd.0009495","volume":"15","author":"F Bernardes Filho","year":"2021","unstructured":"Bernardes Filho F, Silva CML, Voltan G, Leite MN, Rezende ALRA, de Paula NA, Barreto JG, Foss NT, Frade MAC. Active search strategies, clinicoimmunobiological determinants and training for implementation research confirm hidden endemic leprosy in inner S\u00e3o Paulo, Brazil. PLoS Negl Trop Dis. 2021;15(6):e0009495. https:\/\/doi.org\/10.1371\/journal.pntd.0009495.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"12483_CR50","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3201\/eid1805.111018","volume":"18","author":"CG Salgado","year":"2012","unstructured":"Salgado CG, Ferreira DV, Frade MA, Guimar\u00e3es Lde S, da Silva MB, Barreto JG. High anti-phenolic glycolipid-I IgM titers and hidden leprosy cases, Amazon region. Emerg Infect Dis. 2012;18(5):889\u201390. https:\/\/doi.org\/10.3201\/eid1805.111018.","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"12483_CR51","doi-asserted-by":"publisher","first-page":"e0251631","DOI":"10.1371\/journal.pone.0251631","volume":"16","author":"MB da Silva","year":"2021","unstructured":"da Silva MB, Li W, Bouth RC, Gobbo AR, Messias ACC, Moraes TMP, Jorge EVO, Barreto JG, Filho FB, Conde GAB, Frade MAC, Salgado CG, Spencer JS. Latent leprosy infection identified by dual RLEP and anti-PGL-I positivity: implications for new control strategies. PLoS ONE. 2021;16(5):e0251631. https:\/\/doi.org\/10.1371\/journal.pone.0251631.","journal-title":"PLoS ONE"},{"issue":"11","key":"12483_CR52","doi-asserted-by":"publisher","first-page":"e0009913","DOI":"10.1371\/journal.pntd.0009913","volume":"15","author":"X Chen","year":"2021","unstructured":"Chen X, Zha S, Shui TJ. Presenting symptoms of leprosy at diagnosis: clinical evidence from a cross-sectional, population-based study. PLoS Negl Trop Dis. 2021;15(11):e0009913. https:\/\/doi.org\/10.1371\/journal.pntd.0009913.","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"12483_CR53","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/14787210.2020.1752194","volume":"18","author":"VS Santos","year":"2020","unstructured":"Santos VS, de Souza CDF, Martins-Filho PRS, Cuevas LE. Leprosy: why does it persist among us? Expert Rev Anti Infect Ther. 2020;18(7):613\u20135. Epub 2020 Apr 17.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"4","key":"12483_CR54","doi-asserted-by":"publisher","first-page":"e58708","DOI":"10.7759\/cureus.58708","volume":"16","author":"S Sinha","year":"2024","unstructured":"Sinha S, Haq MA, Ahmad R, Banik S, Kumar S, Haque M. Unmasking the hidden burden: A delayed diagnosis of leprosy patients with grade 2 disability and its effects on the healthcare system in Bangladesh. Cureus. 2024;16(4):e58708. https:\/\/doi.org\/10.7759\/cureus.58708.","journal-title":"Cureus"},{"key":"12483_CR55","doi-asserted-by":"publisher","first-page":"893653","DOI":"10.3389\/fitd.2022.893653","volume":"3","author":"M Sharma","year":"2022","unstructured":"Sharma M, Singh P. Advances in the diagnosis of leprosy. Front Trop Dis. 2022;3:893653. https:\/\/doi.org\/10.3389\/fitd.2022.893653.","journal-title":"Front Trop Dis"},{"issue":"4","key":"12483_CR56","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2471\/BLT.23.290881","volume":"102","author":"P Kukkaro","year":"2024","unstructured":"Kukkaro P, Vedithi SC, Blok DJ, van Brakel WH, Geluk A, Srikantam A, Scollard D, Adams LB, Duck M, Anand S, Tucker A, Cruz I, Pemmaraju V, Dagne DA, Asiedu K, Hanna C. Target product profiles: leprosy diagnostics. Bull World Health Organ. 2024;102(4):288\u201395. https:\/\/doi.org\/10.2471\/BLT.23.290881. Epub 2024 Feb 22.","journal-title":"Bull World Health Organ"},{"key":"12483_CR57","doi-asserted-by":"publisher","first-page":"e20200197","DOI":"10.1590\/0037-8682-0197-2020","volume":"53","author":"RS Gama","year":"2020","unstructured":"Gama RS, Leite LA, Colombo LT, Fraga LAO. Prospects for new leprosy diagnostic tools, a narrative review considering ELISA and PCR assays. Rev Soc Bras Med Trop. 2020;53:e20200197. https:\/\/doi.org\/10.1590\/0037-8682-0197-2020.","journal-title":"Rev Soc Bras Med Trop"},{"key":"12483_CR58","doi-asserted-by":"publisher","unstructured":"Frade MC et al. Unexpectedly high leprosy seroprevalence detected using a random surveillance strategy in midwestern Brazil: a comparison of ELISA and a rapid diagnostic test. PLoS Negl Trop Dis, 2017;23;11(2): e0005375. https:\/\/doi.org\/10.1371\/journal.pntd.0005375.","DOI":"10.1371\/journal.pntd.0005375"},{"issue":"1","key":"12483_CR59","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41572-024-00575-1","volume":"10","author":"ML Grijsen","year":"2024","unstructured":"Grijsen ML, Nguyen TH, Pinheiro RO, Singh P, Lambert SM, Walker SL, Geluk A, Leprosy. Nat Rev Dis Primers. 2024;10(1):90. https:\/\/doi.org\/10.1038\/s41572-024-00575-1.","journal-title":"Nat Rev Dis Primers"},{"key":"12483_CR60","doi-asserted-by":"publisher","first-page":"698495","DOI":"10.3389\/fmed.2021.698495","volume":"8","author":"KKPE Silva","year":"2021","unstructured":"Silva KKPE, de Oliveira EE, Elias CMM, Pereira IE, Pinheiro RO, Sarno EN, Duthie MS, Teixeira HC. Serum IgA antibodies specific to M. leprae antigens as biomarkers for leprosy detection and household contact tracking. Front Med (Lausanne). 2021;8:698495. https:\/\/doi.org\/10.3389\/fmed.2021.698495.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"12483_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/ijmr.IJMR_2625_19","volume":"151","author":"K Sardana","year":"2020","unstructured":"Sardana K, Khurana A. Leprosy stigma & the relevance of emergent therapeutic options. Indian J Med Res. 2020;151(1):1\u20135. https:\/\/doi.org\/10.4103\/ijmr.IJMR_2625_19.","journal-title":"Indian J Med Res"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12483-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12483-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12483-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:16:21Z","timestamp":1781626581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12483-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12483"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12483-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7510367\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In accordance with the Declaration of Helsinki, the Institutional Review Board for Human Research at the Hospital of the Medical School of Ribeir\u00e3o Preto, University of S\u00e3o Paulo, approved the study (CAAE: 37734720.4.0000.5440; protocol number: 4.277.546). All patients\/participants provided written informed consent for their data to be analyzed. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"258"}}